Drug repurposing in the era of COVID-19: a call for leadership and government investment
- PMID: 32372435
- PMCID: PMC7267456
- DOI: 10.5694/mja2.50603
Drug repurposing in the era of COVID-19: a call for leadership and government investment
Keywords: COVID-19; Drug industry; Drugs, generic; Infectious diseases; Medicine, traditional; Policy, drugs and alcohol; Respiratory tract infections; Virology.
References
-
- European Medicines Agency . EMA gives advice on the use of non‐steroidal anti‐inflammatories for COVID‐19 [press release]. 18 Mar 2020. https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-ant... (viewed Apr 2020).
-
- National AIDS Treatment Advocacy Project . The coronavirus conundrum: ACE2 and hypertension edition [press release]. 24 Mar 2020. http://natap.org/2020/COVID/032320_16.htm (viewed Apr 2020).
-
- Harrison C. Coronavirus puts drug repurposing on the fast track. Nat Biotech 2020; 38: 379–381. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
